Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 78Lymphoma 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 69Leukemia 69Lymphoma, Non-Hodgkin 68Multiple Myeloma 64Leukemia, Lymphocytic, Chronic, B-Cell 63Lymphoma, Large B-Cell, Diffuse 61Myelodysplastic Syndromes 59Lymphoma, Follicular 59Hodgkin Disease 58Lymphoma, Mantle-Cell 52Lymphoma, Large-Cell, Immunoblastic 48Burkitt Lymphoma 47Lymphoma, B-Cell, Marginal Zone 41Leukemia, Myeloid, Chronic-Phase 40Leukemia, Myeloid, Accelerated Phase 40Congenital Abnormalities 39Neoplasms, Plasma Cell 37Myeloproliferative Disorders 37Leukemia, Myelomonocytic, Chronic 31Waldenstrom Macroglobulinemia 29Recurrence 29Blast Crisis 29Primary Myelofibrosis 23Leukemia, Myelogenous, Chronic, BCR-ABL Positive 23Anemia, Refractory, with Excess of Blasts 21Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 20Dendritic Cell Sarcoma, Interdigitating 20Lymphoma, Large-Cell, Anaplastic 19

Interventions

varlilumab 1liposomal doxorubicin 1Rituximab 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1Immunoglobulin G 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Disulfides 1Cytarabine 1Cyclophosphamide 1Carmustine 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Lymphoma, Primary Effusion × Peripheral Blood Stem Cell Transplantation × Clear all
NCT00345865 2020-07-14

Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
473 enrolled 16 charts
Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Primary Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡